Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.63% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 1.29% |
| 4 | Communication Services | 0.93% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Playboy Inc
PLBY
$144M
| $15.7M | ﹤0.01% |
664,967
+72,905
| +12% | +$1.96M |
|
|
MRTX
2227
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.7M | ﹤0.01% |
88,584
+25,775
| +41% | +$4.15M |
|
2228
CALL
eHealth
EHTH
$36.5M
| $15.7M | ﹤0.01% |
386,600
-15,600
| -4% | -$727K |
|
2229
PUT
Upwork
UPWK
$1.11B
| $15.7M | ﹤0.01% |
347,700
+96,800
| +39% | +$4.72M |
|
|
VTLE
2230
CALL
DELISTED
Vital Energy
VTLE
| $15.7M | ﹤0.01% |
193,100
-68,800
| -26% | -$4.21M |
|
2231
PUT
Applovin
APP
$105B
| $15.6M | ﹤0.01% |
216,100
+61,900
| +40% | +$4.21M |
|
|
CLR
2232
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $15.6M | ﹤0.01% |
338,770
-130,542
| -28% | -$4.93M |
|
2233
CALL
SkinHealth Systems
SKIN
$90M
| $15.6M | ﹤0.01% |
601,800
-8,100
| -1% | -$178K |
|
2234
CALL
W.P. Carey
WPC
$16B
| $15.6M | ﹤0.01% |
218,188
+80,455
| +58% | +$6.12M |
|
2235
iShares Biotechnology ETF
IBB
$10.8B
| $15.6M | ﹤0.01% |
96,327
-126,694
| -57% | -$21.3M |
|
2236
CALL
AMN Healthcare
AMN
$1.36B
| $15.6M | ﹤0.01% |
135,600
+120,900
| +822% | +$12.8M |
|
2237
PUT
T. Rowe Price
TROW
$24B
| $15.5M | ﹤0.01% |
79,000
+8,300
| +12% | +$1.75M |
|
2238
PUT
iShares TIPS Bond ETF
TIP
$15.1B
| $15.5M | ﹤0.01% |
121,600
-195,500
| -62% | -$25.2M |
|
|
OPTU
2239
CALL
Optimum Communications Inc
OPTU
$389M
| $15.5M | ﹤0.01% |
747,600
+301,100
| +67% | +$8.77M |
|
2240
Star Bulk Carriers
SBLK
$3.4B
| $15.5M | ﹤0.01% |
643,801
+129,952
| +25% | +$2.73M |
|
2241
CALL
Yelp
YELP
$1.22B
| $15.5M | ﹤0.01% |
415,200
+72,700
| +21% | +$2.75M |
|
2242
CALL
Tenet Healthcare
THC
$21.6B
| $15.4M | ﹤0.01% |
231,600
+200
| +0.1% | +$14.2K |
|
|
BBL
2243
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $15.3M | ﹤0.01% |
302,748
-24,068
| -7% | -$1.45M |
|
2244
Equifax
EFX
$22.4B
| $15.3M | ﹤0.01% |
60,541
+30,121
| +99% | +$7.83M |
|
2245
PUT
StoneCo
STNE
$2.2B
| $15.3M | ﹤0.01% |
441,900
-123,900
| -22% | -$6.43M |
|
2246
Iovance Biotherapeutics
IOVA
$3.74B
| $15.3M | ﹤0.01% |
621,039
-194,809
| -24% | -$4.59M |
|
|
HBI
2247
CALL
DELISTED
Hanesbrands
HBI
| $15.3M | ﹤0.01% |
892,200
-282,600
| -24% | -$5.3M |
|
|
NNDM
2248
Nano Dimension
NNDM
$333M
| $15.3M | ﹤0.01% |
2,714,174
-4,565
| -0.2% | -$28.7K |
|
2249
PUT
Eaton
ETN
$162B
| $15.3M | ﹤0.01% |
102,500
-67,600
| -40% | -$10.8M |
|
2250
PUT
Sprouts Farmers Market
SFM
$7.56B
| $15.3M | ﹤0.01% |
660,200
+128,800
| +24% | +$3.14M |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.